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Abstract

Genome editing has become an important tool in identifying the specific function
and role of a gene in an organism. With the advent of genome editing using clustered
regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated (Cas)
systems, editing a gene has become much easier and less expensive. This CRISPR/Cas9
system uses a small 20 nucleotide long guided RNA (gRNA), which along with Cas9 will
bind to the target site and cleave it. In this research, CRISPR/Cas9 system was used to
knock out the inducible cAMP early repressor (ICER) promoter sequence in zebra fish.
ICER has anti-proliferative activity and acts as a tumor suppressor. In Ras-induced
melanoma, ICER protein is being targeted to degradation. Knocking out the ICER gene
will help us to establish the tumorigenicity of ICER in melanomas.

A gRNA, specific towards the ICER promoter sequence was designed in an
attempt to cleave it with Cas9. Plasmids pDR274(-)atgICER and pMLM3613 were used
to generate gRNA and Cas9mRNA via in vitro transcriptions. To check the efficiency of
designed gRNA in vitro, PAC-2 cell lines were transfected with a plasmid that expressed
both gRNA and Cas9. The results demonstrate the ability of Cas9 to cleave the target
sequence. In the future, this plasmid could be used to perform microinjection in zebra fish
embryos with the generated gRNA and Cas9mRNA.
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Introduction

A critical role in biology is to determine the function of each gene \ Gene editing
is one fascinating tool that enables us to study and determine the function of an individual
gene in an organism. Earlier, gene functions were determined using forward genetics
screening methods like chemical mutagenesis and transposon mediated mutagenesis 2’3.
Even though these methods were initially successful, each had its own procedure to
determine the mutated site and the whole process is laborious and time consuming 4.
With the advent of new and affordable sequencing methods, the complete genome
sequence of an organism is more readily available. This led to the study of specific gene
function using reverse genetics techniques. Some of the reverse genetics techniques
include 1) partial gene knock down by R N A i5’6, 2) virus induced gene silencing 7, 3)
insertional mutagenesis and 4) chemical mutagenesis/ targeted induced local lesions in
genomes (TILLING). All of these methods have some limitations. For example, gene
silencing using RNAi has unpredictable off targets and the result varies between
experiments 8' 6. Methods like TILLING need large mutant populations and are expensive
. The demand for more precise study on genes and their functions, led to the
development of new gene editing techniques, which are more effective and less
expensive.

In the past decade, a new genome editing approach emerged that enabled a gene
to be edited using engineered nucleases 2?6?9. This approach relies on DNA repair that
occurs when a double stranded DNA is cleaved. The two main types of DNA repair
mechanism to repair double stranded breaks are non-homologous end joining method
(NHEJ) and homologous recombination repair (H R )2. Non-homologous end joining
7

repair could result in nucleotide insertion or deletion (indels), which in turn may affect
the gene function 10. The genome editing tools like zinc finger nucleases (ZFNs) and
transcription activator-like effector nucleases (TALENs) cut the DNA at specific sites
and stimulate DNA repair mechanisms such as, NHEJ repair and HR, allowing study of
gene function 6.

Zinc finger nucleases are a combination of a zinc finger domain and Fkol
nucleases. Zinc finger domains are a small yet common motif observed in proteins,
especially in DNA binding proteins 6. A different Zinc finger domain binds to a different
nucleotide triplet in the major groove of the DNA. This nucleotide specificity of this zinc
finger domain along with the nucleases Fkol allows precise cleavage within the target
gene. Even though this method was successful, it had a few limitations, a) the
corresponding zinc finger domains have not been discovered for all nucleotide triplets, b)
production of zinc finger nuclease is highly labor intensive, time-consuming and very
expensive 6.

Like ZFNs, another effective tool for genome editing with relatively rare off
target effect is TALENs. TALEN is a combination of TALE and Fkol nuclease. TALE
(transcription activator-like effector) was first discovered in plant pathogens
Xanthomonas s p 2 and it has a DNA binding domain with 30 -35 tandem amino acid
repeats that recognize a single, specific nucleotide in DNA 2’8. The amino acid residues
within this repeats are highly conserved and changes within these amino acid residues
contributes to its different binding specificity. The successful outcome in gene editing
using TALE depends on the tandem repeats. At the same time, constructing a TALE with
many repeats is laborious and time consuming.
8

In spite of the site specific cleavage achieved using the above ZFNs and TALENs,
the discovery of type II CRISPR/Cas system emerged as a more efficient gene editing
tools. This CRISPR/Cas system, also called the RNA guided nucleases genome editing
tool, has been proven to be very simple, cost effective, less time-consuming and can be
applied on all organisms n ’12,13,14. In this system, a small piece of processed RNA guides
Cas nuclease to specifically cleave the DNA to which it binds.

Type II CRISPR/Cas system is an adaptive immune mechanism used by many
bacteria against invading pathogens, especially viruses 15,16,17. In this process, bacteria
incorporates a short sequence of a genetic element from the invading pathogen into its
genome, at a unique site called the clustered regularly interspaced short palindromic
repeats or CRISPR loci. This CRISPR is composed of short tandem repeats of
approximately 30-40 base pairs (bp). The sequence from the invading pathogen called the
spacer/protospacer is incorporated between the CRISPR repeats 18,19,20. Following an
attack, the CRISPR responds to the invading pathogen, by transcribing and processing the
protospacer sequence at the CRISPR locus to produce CRISPR RNA (crRNA).The
crRNA consists of the sequence from the invading pathogen and it is flanked by part of
the CRISPR repeat. This crRNA hybridizes with the trans-activating RNA (tracrRNA)
and forms a complex with the Cas9 protein (Cas9 protein contains RuvC nucleases and
HNH nuclease domain). The crRNA then binds to its complementary target DNA and
directs Cas9 nuclease to cleave the DNA-1, 22. Overall, genome editing using
CRISPR/Cas9 requires only two components: a small crRNA specific towards the target
site and a Cas9 enzyme to cleave the target site. This eliminates the complication of
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designing multiple zinc fingers as required by ZFNs and repetitive amino acid sequence
as required by TALENs at target site 23,24.

Researchers have used this CRISPR/Cas system from Streptococcus pyogenes
(S.pyogenes) to edit the genome in recent years. This was done by expressing the Cas9
protein and a small guided RNA called gRNA (a fusion between crRNA and tracrRNA)
complementary to the target DNA that is to be cleaved. Recent in vitro and in vivo studies
have successfully employed this mechanism in a few model organisms like zebra fish,
fruit flies, and mice

’11,25. The only constraints with this system are: the size of the

gRNA should be 20 nucleotides long and the target site should be immediately followed
by a protospacer adjacent motif called PAM. The PAM sequence is necessary for gRNA
to direct Cas9 to cleave the target DNA 21,26,21. The most recognized PAM sequence is
5’-NGG-3’. Sometimes a PAM site with 5’-NGA-3’ is also recognized, but with less
efficiency. Thus, Cas9 protein could be directed to cleave any DNA site in the form of
N20-NGG, by simply creating a complementary gRNA 15,23,28,29. This form of gene
editing tool has made it very easy for scientists to study and determine the function of
specific genes. This type II CRISPR/Cas9 gene editing tool was used in this study to edit
the promoter of the induced cyclicAMP early repressor (ICER) in zebra fish cells.
Melanoma is a skin cancer that is rapidly growing in western countries. It
develops in the melanocytes located in the epidermis of the skin32,33. It is caused by
mutations in B-Raf, N-Ras and H-ras by UV exposure. Mutations, in these proto
oncogenes, leads to loss of cell cycle control and results in uncontrolled cell proliferation.
In melanocytes, increased levels of cyclic AMP (cAMP) are observed, which positively
regulates cell growth and differentiation. Increased levels of cAMP regulate the
10

transcription of many cellular genes. This signaling pathway requires the activation of
transcription factors by protein kinase A (PKA). PKA phosphorylates many transcription
factors like CREB (cyclicAMP- response element binding protein), CREM (cyclicAMP response element modulators) and the ATF gene family 32,30,33. Upon phosphorylation
by PKA, these transcription factors activate CRE-containing genes. CREM is a unique
gene that generates gene activators and repressors by alternate splicing 30. One of the
products of the CREM gene that is not activated by PKA is the ICER protein. The CREM
gene consists of two promoters PI and P2. Both PI and P2 are induced by cAMP 2a 31.
ICER is a product of P2, which is not regulated by PKA. ICER acts as a potent inhibitor
of cAMP inducible responses. When the cAMP level increases within a cell, ICER binds
to CREs on the CREB/CREM gene as a homodimer or heterodimer and negatively down
regulates cAMP gene expression 31. This function of ICER is important to manage cAMP
genes, and in keeping the delicate balance that is necessary for proper gene regulation.
This negative down regulation of ICER prevents the cancer cells from growing in an
anchorage - independent manner 30’37. Recent studies have demonstrated that increased
cAMP levels contribute to melanocyte growth and differentiation, thus resulting in
melanoma 3

4. In the case of Ras induced melanoma, ICER has been targeted for

degradation by Ras, thereby preventing the down regulation of cAMP genes. This
indicates the significant role of ICER as a tumor suppressor in preventing melanoma. By
knocking out the ICER promoter sequence using CRISPR/Cas9 system in zebra fish, it
may be possible to establish the role of ICER in melanoma.
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Outline of Research and Designing gRNA
The aim of this study was to knock out the ICER gene promoter. The first step
was to identify the potential target site for gRNA. ZiFiT Targeter 10 was used to identify
the potential target site for gRNA. This was done by submitting the ICER sequence to
the ZiFiT website. Out of four suggested target sites, the site that contained part of the
ICER promoter, with adjacent PAM sequence was selected.

ICER Sequence
CTTCTGAGCTT AAAT A AAT AAAT ATGCAACTGC ACT ATTTTTTT AAGC AATGA
AT AT AAGCTTGT ATGTT AAT AT AAA ATGAGTCCTGTTTCTCTCTCTCTTTC AC A
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT
ATTTCCCTGTGAGGCTGCTGTG ATGTC AT AGTGATGTCAATGCCCTT AATAGT
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT
AGGGAAGGAGAGAGAGGGTT AAAGGGAAAC AGT AAGTGTC AC AACTCT AAC
AGAGAGTCAGTAGGAGCGCGTGAGAGAGAAACTCAGCCAGCGAAGAGCTGA
AGGG A AG AC AG AGCTTT AAT AGG A A AT C A AG AGG A A AC ACT AT CCC A ACT G
GATT ACT AC AGT AT AG AG ATGGC AGTGACCGGGGAAGA AACCG AGTC AGCT
GCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTGC
CTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAACC
CAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACAG
GGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTTT
GGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTTAAAGACATCTACTGCCACAAGCCTGAATAACCCTCACAA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTT ATCGCT
The sequence in Yellow indicates the gRNA target sequence .The sequence in red color
(ATG) indicates the start codon.
The research was done in two stages:
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Stage 1- Production of mRNA for in vivo gene alterations study
Two separate vectors, pDR274 and pMLM3613, were used to express gRNA and
Cas9. Both gRNA and Cas9 sequence were under the control of the T7 promoter.
Previous studies

'

suggested that the T7 promoter requires a pair of Guanine or

Adenine residues at the 5’ end of the transcript. So the gRNA sequence should be in the
form of 5’-- GG/AA-N18-NGG-3’.

The following sequence 5’ - GGATTACTACAGTATAGA - 3’ was cloned in to
the vector pDR274. pDR274 harboring the 5’ GGATTACTACAGTATAGA -3’ gRNA
sequence was transcribed in vitro following the MAXIscript® kit manufacturer’s
protocol (Life Technologies, Grand Island, NY, USA). Cas9 sequence, under the control
of theT7 promoter in the vector pMLM3613, was transcribed in vitro following the
mMessage mMachine T7 ultra kit manufacturer’s protocol ( Life technologies, Grand
Island, NY, USA). Since Cas9 is an enzyme a 3’ poly (A) tail and a 5’ cap were added to
the mRNA sequence. The mRNA of both gRNA and Cas9 was purified by lithium
chloride precipitation and stored.

Stage 2 - In vitro study of CRISPR/Cas9 system in zebra fish cells
A single vector system that carried both gRNA and Cas9 sequences along with
the sequence for GFP expression was used. This single vector system enhanced the
chance of equal delivery of all CRISPR/Cas components into the cells. The presence of
the GFP sequence in the vector made it easy to determine the percentage of transfected
cells using a fluorescent microscope. When the construct was transfected into the zebra
fish cells, and if the gRNA bound specifically to the target site, it would direct the Cas9
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nuclease to cleave the target DNA. Cleavage by Cas9 nucleases on the target sequence
could be determined by amplifying the ICER sequence using PCR and performing a T7
endonuclease assay on the amplified DNA. A positive result would indicate the
efficiency of CRISPR/Cas9 system on the ICER sequence in zebra fish. In the future,
Cas9mRNA and gRNA (generated in stage 1) could be used to perform microinjection in
zebra fish embryos.
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pCMVCas9GFP(-)atgICER contains the sequence for gRNA, Cas9 and GFP. U6
promoter drives gRNA expression and CMV promoter drives Cas9 expression.
pCMVCas9GFP(-)atgICER was purchased from Sigma (Sigma-Aldrich, St. Louis, MO,
U S A ).
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Materials and methods
Identifying gRNA target site

The ZiFiT Targeter (http://zifit.partners.org/ZiFiT/) was used to identify the
potential target site for gRNA. The ZiFiT site also gives the list of oligonucleotide
sequences necessary for cloning the target sequence into the pDR274 vector.
Target site - 5’ - GG ATT ACT AC AGT AT AG A - 3’
Oligonucleotide sequence 1 - 5’- TAGG ATT ACT AC AGT AT AG AG A - 3’
Oligonucleotide sequence 2 - 5’ - AAACTCTCTATACTGTAGTAAT - 3’
Stage-1
pDR274atg(-)ICER construction.
E.coli cells containing pDR274 plasmid were purchased from Addgene
(Cambridge, MA, USA). These bacterial cells were grown on an agar plate containing
kanamycin, and then plasmid pDR274 was isolated following QIAprep® spin Miniprep
protocol (Qiagen, Valencia, CA, USA). pDR274 contains the T7 promoter. To this the
20 nucleotide target sequence (gRNA) was incorporated as following the protocol
detailed below.
pDR274 digestion and DNA extraction from agarose gel
Ten microliters of pDR274 were mixed with 2 pL of lOx BufferG, 2 pL of Bsal
(Thermo fisher scientific, Waltham, MA, USA), and 6 pL of double distilled water and
incubated at 37°C for 1 hour. The reaction mixture was then run on 1% agarose gel at
100V for 1 hour. The DNA was extracted according to the QIAquick® gel extraction kit
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(Qiagen, Valencia, CA, USA) protocol. The band of interest (approx. 2147bp) was
excised from the gel, placed in 1.5mL micro centrifuge tube and weighed. To this QC
buffer was added in the ratio of 1:3 (Gel: QC buffer). The solution was then placed on a
heating block at 50°C for 10 minutes, mixing every 3 minutes. To this isopropanol was
added in the ratio of 1:1 (Gel: Isopropanol). The solution was then placed on a DNA
specific column and purified according to the manufacturer’s protocol. DNA
concentration was measured with the Nanodrop spectrophotometer.

Ligation of oligonucleotide (gRNA) into pDR274
The forward and reverse oligonucleotides were reconstituted (1.5pg/pL) and were
mixed together in the ratio of 1:1. The oligonucleotides were annealed by placing them
in a beaker containing water at 94°C and were then allowed to cool to less than 30°C on
the bench. Then oligonucleotides were allowed to cool to room temperature overnight.
Following annealing, different dilutions of inserts (annealed oligos) were prepared (1:5,
1:10, 1:50, 1:100). DNA ligation was done following manufacturer’s protocol (DNA
ligation Kit ver. 1 Manual, Takara, Clone Tech Laboratories, Mountain view, CA, USA).
Five microliters of linearized vector pDR247 (extracted from the gel) was mixed with
5pL of insert at various concentrations (1:5, 1:10, 1:50 and 1:100). To this 5 0 p L o f
solution A and 10 pL of solution B were added. The solutions were incubated at 16°C
for 30 minutes.

DNA transfection and sequencing
DNA transfection was done following One Shot® Top 10 competent cell
transformation protocol (Invitrogen, Carlsbad, CA, USA). Five microliters of ligate was
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added to 50 pL of One Shot® Top 10 competent cells (1 vial of cells for each dilution).
The vials were incubated on ice for 20 minutes. Following incubation on ice, the vials
were incubated in a water bath at 42°C for 30 seconds. Then the vials were immediately
placed on ice. To this 250 pL of pre-warmed S.O.C medium was added and the vials
were kept in a shaking incubator for 1 hour at 225RPM. Following transformation, 200
pL of the mixture from each vial were spread on labeled LB agar plates containing
kanamycin, and were incubated at 37°C overnight. Following incubation, plasmids were
isolated from the transfected cells according to the QIAprep® spin Miniprep protocol
(Qiagen, Valencia, CA, USA). Once the plasmids were isolated, the DNA samples were
sent to GeneWiz (South Plainfield, NJ, USA) for sequencing to check for the proper
ligation of target sequence (gRNA) in to pDR274 vector.

In vitro transcription of Cas9mRNA and gRNA
Restriction Digestion of pDR274(-)atgICER and pMLM3613
The expression vector, pMLM3613, containing the gene for Cas9 was purchased
from Addgene (Cambridge, USA). These bacterial cells were plated on agar dishes
containing kanamycin. Following incubation, pMLM3613 were isolated from the
bacterial cells. Both pDR274(-)atgICER and pMLM3613were isolated following
QIAprep spin Miniprep protocol (Qiagen, Valencia, CA,USA ). Additionally, pDR274()atgICER was linearized with Dral (Invitrogen, Carlsbad, CA, USA). In a 1.5mL
microcentrifuge tube, 12 pL of pDR274(-)atgICER, 2 pL lOx buffer B, 1 pL of Dral, and
5 pL of ultra-pure water were combined and incubated at 37°C for 5 hours. Similarly,
pMLM3613 was linearized with Pmel (Invitrogen, Carlsbad, CA, USA). In a 1.5mL
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microcentrifuge tube, 11 pL of pMLM3613, 6 pL ultra-pure water, 2 pL lOXbuffer B
and 1 ¡iL of Pmel were combined and incubated at 37°C for 5 hours. The digested
samples were then mixed with 2 pL of loading buffer and run on 1% agarose gel
(containing ethidium bromide) at 100 volts for 60 minutes in lxTAE buffer. The bands
were observed under gel dock.

Production of Cas9mRNA and gRNA

The linearized plasmid pDR274(-)atgICER and pMLM3613 were extracted from
the gel according to the QIAquick® gel extraction kit protocol (Qiagen, Valencia, CA,
USA), and the concentration of the plasmids were measured with Nanodrop
spectrophotometer. The linearized plasmids pDR274(-)atgICER and pMLM3613 were
used as templates for gRNA and Cas9mRNA in vitro transcription. pDR274 (-)atglCER
was transcribed following MAXIscript® kit manufactures protocol ( Life Technologies,
Grand Island, NY, USA) . In a 1.5 mL microcentrifuge tube, 80 pL of nuclease free
water, 10 pL of pDR274(-)atgICER, 2 pL of 10X transcription buffer, 1 pL of 10 mM
ATP, 10 mM CTP, 10 mM GTP, 10 mM UTP each, 4 pL of T7 (15U/ pL) enzyme were
added and mixed thoroughly. The solution was incubated at 37°C for 1 hour. Following
incubation, 1 pL of TURBO DNase (2U/ pL) (Life Technologies, Grand Island, NY,
USA) was added and incubated at 37°C for 15 minutes.
The expression vector, pMLM3613, was transcribed following the mMessage
mMachine T7 ultra kit manufacturer’s protocol ( Life Technologies, Grand Island, NY,
USA). In a 1.5 mL microcentrifuge tube, 20 pL of nuclease free water, 10 pL of T7 2X
NTP/ARCA, 2 pL of 10X T7 reaction buffer, 6 pL of pMLM3613 and 2 pL of T7 (15U/
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pL ) enzyme were added. The solution was incubated at 37°C for 1 hour. To this, 1 pL of
TURBO DNase (2U/ pL) was added and incubated for 15 minutes at 37°C. Following
transcription a 3’poly (A) tail was added according to the of mMessage mMachine® T7
ultra kit protocol (Life Technologies, Grand Island, NY, USA). To the incubated
solution, 20 pL of mMessage mMachine® T7 ultra reaction, 36 pL of nuclease free
water, 20 pL of 5X E —PAP buffer, 10 pL of Mncl2 and 10 pL of ATP solution were
mixed together. The solution was incubated at 37°C for 40 minutes. After the addition of
the 3’ poly (A) tail and the 5’ cap, the Cas9mRNA was recovered by lithium chloride
(LiCl) precipitation and was re-dissolved in RNase free water. The concentration of both
gRNA and Cas9 mRNA were measured with Nanodrop spectrophotometer.
Stage-2

pCMV Cas9GFP(-)atgICER

The vector, pCMVCas9GFP(-)atgICER ( the gRNA sequence was cloned into the
vector pCMVCas9GFP by Sigma, to generate pCMVCas9GFP(-)atgICER ) was
purchased from Sigma (Sigma-Aldrich, St. Louis, MO,USA). The vector contains the
gRNA, Cas9 and GFP sequence. The gRNA was expressed under the U6 polymerase III
promoter and Cas9 was expressed under the CMV promoter.

Transfection of pCMVCas9(-)atgICER in PAC-2 cells.
Two PAC-2 cell culture flasks were used. One PAC-2 cell culture flask was
transfected with pCMVCas9GFP(-)atgICER using FuGENE HD transfection reagent
(Promega, Madison, WI, USA ) and the other flask was transfected with pCMVEGFP.
Briefly, 6 pL of pCMVCas9GFP(-)atgICER, 270 pL of LS media and 24 pL of FuGENE
19

were combined, and added to the PAC-2 cells. Similarly, 20 pL of pCMVEGFP, 256 pL
of LS media and 24 pL of FuGENE were combined and added to the second PAC-2 cell
culture flask. This served as a control. Both the flasks were incubated at 25°C for 48
hours.

Genomic DNA Extraction

Following 48 hours of incubation and prior to genomic DNA extraction, the cells
were observed under fluorescent microscope and the transfection efficiency was
determined. Genomic DNA was extracted using GeneArt ©Genomic cleavage Detection
Kit (Life technologies, Grand Island, NY, USA). Briefly, the transfected PAC-2 cells
were washed three times with lm L of 0.1% PBS. After a final wash 500 pL of 0.1%
PBS was added and then the cells were scraped. The cells were then transferred into
1.5mL centrifuge tube and were centrifuged at 2000 g for 5 minutes at 4°C. The
supernatant was removed, and to the pellet, 50 pL of cell lysis buffer and 2 pL of protein
degrader were added and the pellets were re-suspended. The entire solution was then
transferred into PCR tubes, and cells were lysed in the thermal cycler. The thermal cycler
parameters for lysis were: 68°C for 15 minutes, 95°C for 10 minutes and 4°C on hold.
Primers Used
ICER SEQUENCE
CTTCTGAGCTT AAAT A AAT AA AT ATGC AACTGC ACT ATTTTTTT AAGC AATGA
AT AT A AGCTTGT ATGTT AAT AT AAAATG AGTCCTGTTTCTCTCTCTCTTTCAC A
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT
ATTT CCCT GTG AGGCTGCT GTG ATGTC AT AGT GAT GT C A AT GCCCTT AAT AGT
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT
AGGGAAGGAGAGAGAGGGTTAAAGGGAAACAGTAAGTGTCACAACTCTAAC
agagagtcagtag1 agcgcgtgagaga1 aaac| cagccagcgaaga1 ctga
AGGGAAGACAGAGCTTTAATAGGAAATCAAGAGGAAACACTATCCCAACTG
20

GATT ACT AC AGT AT AG AG ATGGC AGTGACCGGGG A AGA AACCG AGTC AGCT
GCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTGC
CTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAACC
CAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACAG
GGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTTT
GGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTT AAAGAC ATCT ACTGCC AC AAGCCTGAAT AACCCTC AC AA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTTATCGCTCAAA^HHATTGTGCAGGGCCGTfTTGT
TTGTTTGTT

Primers Used
Primer set 1: Forward Primer - AGTAGGAGAGAGTGAGAGAG
Reverse primer - TAATAATGTGTGCAGGGCCGT
Primer set 2: Forward Primer - GAGCGCGTGAGAGAGAAACT
Reverse primer - TAATAATGTGTGCAGGGCCGT
Primer set 3: Forward Primer - GAAACTCAGCCAGCGAAGAG
Reverse Primer - TAATAATGTGTGCAGGGCCGT
These three sets of primers were used to amplify the ICER sequence.
Yellow sequence - Indicates the target site in ICER sequence where forward primer 1
anneals in ICER sequence. Red letters - Indicates the start and end of the target site in
ICER sequence where primer 2 anneals. Green letters - The start and end of the target
site in ICER sequence where forward primer 3 anneals. Purple - Indicates the target site
in ICER sequence where reverse primer anneals.

PCR Amplification
Three different sets of primers were designed to amplify the ICER sequence.
OligoAnalyzer 3.1 (http://www.idtdna.com/analvzer/) was used to design primers for
PCR. A total of six reactions were prepared. Briefly, 2 pL of genomic DNA, 1 pL of 10
mM forward primer, 1 pL of 10 mM reverse primer, 25 pL of AmpliTaqGold360 Master
Mix ( GeneArt ©Genomic cleavage Detection Kit, Life technologies, Grand Island, NY,
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USA) and 22 pL of water were combined together in a PCR tube and PCR reaction was
run. The thermal cycler parameters were: 95°C for 10 minutes, 40 cycles of 95°C for 30
seconds, 40 cycles of 55°C for 30seconds, 40 cycles of 72°C for 30 seconds, 72°C for 7
minutes and 4°C on hold. Three microliters of the PCR product, 1.3 pL of lOx loading
buffer and 10 pL of water were combined in a PCR tube and were run on a 2% agarose
gel. Five microliters of DNA ladder (HiLo, Minnesota Molecular Inc, MN, USA) was run
in parallel to compare and estimate the fragment size and DNA concentration of the
products.

Cleavage Assay

The amplified PCR samples were subjected to a cleavage assay. This was done
following the GeneArt® Genomic Cleavage Detection Kit (Life technologies, Grand
Island, NY, USA). Briefly, 3 pL of PCR product, 1 pL of detection reaction buffer and 5
pL of water were combined in a PCR tube. These solutions were then kept in the thermal
cycler for re-annealing. The thermal cycler parameters are: 95°C for 5min, 95°C to 85°C
at the rate of (-2°C)/seconds, 85°C to 25°C at the rate of (-0.1 °C)/seconds, 4°C on hold.
Following re-annealing, 1 pL of detection enzyme was added to the entire mixture and
the samples were incubated in a water bath at 37°C for 1 hour.

Agarose gel electrophoresis
Following enzyme digestion, to each enzyme digested sample, 10 pL of water and
2 pL of lOx loading buffer were added. The samples were then run on a 2% agarose gel
at lOOv for 60 minutes. Five microliters of DNA ladder (HiLo, Minnesota Molecular Inc,
MN, USA) was run in parallel to compare the size of the cleaved products.
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Results
Stagel
Inserting gRNA sequence into pDR274/ construction of pDR274(-)atgICER
The goal of this project was to knockout the ICER promoter by using a gRNA
specifically targeting the ICER promoter sequence followed by the cleavage of Cas9. In
order to produce the vector, pDR274(-)atgICER, plasmid pDR274 was linearized and
analyzed by agarose gel electrophoresis. The band of size 2147 (Figure 1) was excised
and pDR274 was extracted. The concentration of the plasmid was measured with the
NanoDrop spectrophotometer. The total yield of pDR274 was 200 ng/pL. This pDR274
was ligated with gRNA oligonucleotides and the constructs were transfected. The
plasmids extracted from the transfected cells were sequenced. The sequenced data
suggest the successful insertion of gRNA into pDR274. The inserted gRNA
oligonucleotide is highlighted in yellow (Figure 2).

In vitro transcription of Cas9mRNA and gRNA
The vector, pDR274(-)atgICER, was digested and analyzed by agarose gel
electrophoresis. Two bands of approximate size 1885 bp and 282 bp were observed
(Figure 3). The band of size 282 bp that contained the gRNA sequence was excised for
DNA extraction. The concentration of the DNA was measured with a Nanodrop
spectrophotometer and the yield was 1 pg/pL. The extracted DNA was transcribed into
RNA and concentration was measured. The total yield of gRNA was 634.2 ng/pL.
The vector, pMLM3613 was digested and the band of size 8000 bp was extracted
(Figure 2) and the concentration of the DNA was measured. The total yield was 2.2
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^xg/^iL. The extracted DNA was transcribed into RNA and the RNA concentration was
measured. The yield of Cas9mRNA was 1 pg/pL. The RNA was analyzed by a RNA gel
electrophoresis (Figures 4a and 4b).
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2000bp -

-pDR274

Figure 1 - Lane 1-Molecular weight marker (HiLo). Lanes 2 and 3 - pDR274 (-2147)
digested with Bsal.

CCCGTGTAAAACGACGGCCAGTTTATCTAGTCAGCTTGATTCTAGCTGATCGTGGACCGGAAGGTGAGCC
AGTGAGTTGATTGCAGTCCAGTTACGCTGGAGTCTGAGGCTCGTCCTGAATGATATGCGACCGCCGGAGG
GTTGCGTTTGAGACGGGCGACAGATCCAGTCGCGCTGCTCTCGTCGATCCAAGCTTTTTAAAAGCACCGA
CTCGGTGCC ACTTTTTC A AGTTGATAACGGACT AGCCTT ATTTT A ACTTGCT ATTTCT AGCTCTA
TAGGATTACTACAGTATAGAGACCTATAGTGAGTCGTATTAGCTAGCGGTGCGAGCGGATCGAGCAGTGTCG
ATCACTACTGGACCGCGAGCTGTGCTGCGACCCGTGATCTTACGGCATTATACGTATGATCGGTCCACGA
TCAGCTAGATTATCTAGTCAGCTTGATGTCATAGCTGTTTCCTGAGGCTCAATACTGACCATTTAAATCA
TACCTGACCTCCATAGCAGAAAGTCAAAAGCCTCCGACCGGAGGCTTTTGACTTGATCGGCACGTAAGAG
GTTCCA ACTTTC ACCAT A ATG A A ATA AGATC ACTACCGGGCGT ATTTTTTGAGTT ATCGAGATTTTC AGG
AGCTAAGGAAGCTAAAATGAGCCATATTCAACGGGAAACGTCTTGCTTGAAGCCGCGATTAAATTCCAAC
ATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATC
GATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGT
TACAGATGAGATGGTCAGGCTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATC
CGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCAGGGAAAACAGCATTCCAGGTATTAGAAG
AATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCC
TGTTTGTAATTGTCCTTTTAACGGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAAC
GGTTTGGTTGGTGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAA

Figure 2 - Confirmation of gRNA sequence in pDR274 vector. Yellow highlights the
gRNA sequence.

1 2 3 4 5 6 7 8 9

10

Figure 3 - Lane 1- molecular weight (HiLo), Lanes 2-6 - pMLM3613 digested with
Pmel and the band displays the successfully linearized plasmid. Lanes 7-10 - pDR274()atgICER digested with Dral sample and displays 2 distinct bands. The band ~ 282 bp
codes for gRNA sequence.

Figure 4a - Cas9mRNA and gRNA were transcribed in vitro and was run on RNA gel.
Lane 1- Molecular weight 0.5,1,1.5,2,2.5,3,4,5,6 and 9kb, Lane-2— Cas9RNA after
poly(A) tail, Lane-3— Cas9 RNA before poly(A) addition, Lane-4 - gRNA (the band is
faint).
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2

3

4

Long run

1

Figure 4b - Cas9mRNA and gRNA were transcribed in vitro and was run on RNA gel.
Lane 1- Molecular weight 0.5,1,1.5,2,2.5,3,4,5,6 and 9kb, lane-2— Cas9RNA after
addition of poly(A) tail and smeared band was observed, Lane-3— Cas9 RNA before
poly(A) addition, Lane-4 - gRNA band is not visible.
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Stage -2

Transfection of PAC-2 cell line with pCMVCas9GFP(-)atgICER and pCMVEGFP
The transfected cells were observed under a fluorescent microscope. The
percentage of transfection was determined by counting the total number of cells and the
number of cells that emitted fluorescence. The percentage of transfection in the control
flask (PAC-2 cells transfected with pCMVEGFP) and the test flask (PAC-2 cells
transfected with pCMVCas9GFP (-)atglCER) was 14.2% and 8.7%, respectively
(Figures 5a and 5b). Overall, the transfection efficiency was very low in both test and
control flasks.

Table 1 - Percentage of Transfection in PAC-2 cells
PAC-2 Cells
Transfected plasmid
pCMVCas9GFP(-)atgICER
pCMVEGFP

Total Number
of cells
114
140

Fluorescent
cells
10
20

%
Transfection
8.7
14.2

Genomic DNA Extraction and Amplification of ICER
Total genomic DNA was extracted from test (PAC-2 cells transfected with
pCMVEGFP) and control (PAC-2 cells transfected with pCMVCas9GFP(-)atgICER)
cells. The ICER sequence was amplified with PCR. Gel electrophoresis of PCR products
gave a strong band of size 350 bp with all 3 sets of primers (Figure 6).
Cleavage Assay
The PCR products were cleaved with detection enzymes and were analyzed by
agarose gel electrophoresis. The bands obtained in each lane were compared with a
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positive control. Samples amplified with primer set 1 and primer set 2 did not have three
bands as was visible in the positive control. The samples amplified with primer set 3, had
three bands similar to that of the positive control (Figure 7). This indicates that the
cleavage assay was successful and the ICER promoter sequence was knocked out. The
cleavage band that appeared in lane 3(+) was very faint. This suggests that the
transfection efficiency had a major effect on the band strength since only 8% of cells
were transfected.
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5a

5b

Figure 5a - Control- PAC-2 cells transfected with pCMVEGFP (viewed under
fluorescent microscope - 400x).
Figure 5b - Test- PAC- 2 cells transfected with pCMVCas9GFP (-)atglCER (viewed
under fluorescent microscope - 400x).

MW

l(-)

l(+ï

2(~)

2(+)

3(-J

3(+)

+C

Figure 6 - Gel display the PCR amplification. The band of ~350bp indicates that the
ICER sequence has been amplified, l(-) and 1(+) indicates PCR amplification with
primer set 1. 2(-) and 2(+) indicates PCR amplification with primer set 2. 3(-) and 3(+)
indicates PCR amplification with primer set 3. +C indicates positive control (sample from
the gene art kit)
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MW

l(-)

1(+)

2{~)

2(+)

3{-)

3{+)

+C

cleavage band 1
. cleavage band 2

Figure 7- Gel displays the cleavage assay. Lane l(-) and 1(+), Lane 2(-) and 2(+)
displays one band. This indicates that the cleave assay is not positive and ICER promotes
sequence is not cleaved. Lane 3(+) displays cleavage bands similar to that of the +C, and
the 2nd cleavage band is visible, but it is very faint.

31

Discussion

The vector pCMVCas9GFP(-)atgICER successfully knocked out the ICER
promoter sequence in vitro, in PAC-2 cell lines. At the same time, the cleavage bands
obtained, after the cleavage assay, were not very strong. One of the major reasons behind
this was the transfection efficiency in PAC-2 cell lines. The percentage of transfection in
the PAC-2 cell line with a ratio of 8:2 was only 3% and the cleavage assay result was not
positive. In an attempt to increase the transfection efficiency, a ratio of 10:2 was used,
and the percentage of transfection was increased by 5.2%. The cleavage assay was
successful, but the cleavage bands were very faint. The other factor that would have had
an effect on the cleavage assay was the percentage of indels formed. It was demonstrated
that indel mutation less than 2% at the target site will not be cleaved by cleavage
enzymes L\ Since the overall transfection in PAC-2 cells was only 8.2%, it could have
had a major effect in the percentage of indels formed. The other factor that might have
had an effect on the cleavage assay results was the specificity of Cas9 nucleases. Cas9
cleaves the target at the PAM site, and acts efficiently if the PAM sequence is NGG. The
PAM site at the 3’end of the gRNA used in this research is NGA and this might have
reduced the specificity of Cas9.
The other major challenge in this research was to produce a sufficient amount of
gRNA by in vitro transcription. The initial concentration of gRNA after in vitro
transcription was around 43.2 ng/pL. It was believed that lithium chloride worked better
on RNA samples greater than 300 bp and the gRNA used in this research was only 282
bp. In an attempt to increase the gRNA yield, the gRNA was transcribed in vitro again
and the RNA was precipitated with ammonium acetate. The gRNA yield increased and
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the concentration of gRNA was around 634.2 ng/pL. This gRNA concentration should be
sufficient to perform in vivo experiment in zebra fish embryos.

Future Studies
In the future, the gRNA and Cas9mRNA generated in vitro could be used to
perform an in vivo transfection in zebra fish embryos. While performing the
microinjection, it would be good to try various concentrations of gRNA and Cas9mRNA,
since the difference in concentrations may have an impact in the percentage of indel
formations 2\ Future studies should also concentrate on the factors that affect the
transfection efficiency and Cas9 nuclease’s specificity. It is necessary to optimize the
transfection in PAC-2 cells by trying different transfection ratios. A few recent studies
have demonstrated nucleofection as the better transfection method for PAC-2 cell lines

’

36. If possible, transfection efficiency in PAC-2 cells could be studied using different
transfecting reagents, and the reagent that gives better efficiency could be used in future
research. Since in this research the bands obtained after the cleavage assay were very
faint, the DNA sequencing should be done on the PCR products to confirm the presence
of an indel mutation in the target sequence. Since there is a possibility that NAG located
next to the 3’ end of the gRNA at the target site might have had an effect on Cas9
cleavage, in the future, designing a gRNA that satisfies the NGG requirement next to the
3’end may give better results. This could be achieved by extending the current gRNA by
3 bases at the 3’end.
These suggested changes, especially optimizing the transfection efficiency and
increasing Cas9 specificity, may increase the effect of CRISPR/Cas9 system in knocking
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out the ICER promoter sequence in zebra fish cells (in vitro) and in zebra fish embryos
(in vivo). Knocking out the ICER promoter sequence in zebra fish models may establish
the tumorigenicity of ICER in melanomas.
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